Abstract
AbstractImmunodominance of antibodies targeting non-neutralizing epitopes and the high level of somatic hypermutation within germinal centers (GCs) required for most HIV broadly neutralizing antibodies (bnAbs) are major impediments to the development of an effective HIV vaccine. Rational protein vaccine design and non-conventional immunization strategies are potential avenues to overcome these hurdles. Here, we report using implantable osmotic pumps to continuously deliver a series of epitope-targeted immunogens to rhesus macaques over the course of six months to prime and elicit antibody responses against the conserved fusion peptide (FP). GC responses and antibody specificities were tracked longitudinally using lymph node fine-needle aspirates and electron microscopy polyclonal epitope mapping (EMPEM), respectively, to show antibody responses to the FP/N611 glycan hole region were primed, although exhibited limited neutralization breadth. Application of cryoEMPEM delineated key residues for on-target and off-target responses that can drive the next round of structure-based vaccine design.
Funder
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Bill and Melinda Gates Foundation
Publisher
Springer Science and Business Media LLC
Reference86 articles.
1. National Center for Immunization and Respiratory Diseases. General recommendations on immunization – recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 60, 1–64 (2011).
2. Watson, J. C. et al. An evaluation of measles revaccination among school-entry-aged children. Pediatrics 97, 613–618 (1996).
3. Poland, G. A. et al. Measles reimmunization in children seronegative after initial immunization. JAMA 277, 1156–1158 (1997).
4. Banatvala, J. E. & Van Damme, P. Hepatitis B vaccine do we need boosters? J. Viral Hepat. 10, 1–6 (2003).
5. Miner, M. D., Corey, L. & Montefiori, D. Broadly neutralizing monoclonal antibodies for HIV prevention. J. Int AIDS Soc. 24, e25829 (2021).